✦ LIBER ✦

Persistence with teriparatide in patients with osteoporosis: the UK experience

✍ Scribed by N. K. Arden; S. Earl; D. J. Fisher; C. Cooper; S. Carruthers; M. Goater

Publisher: Springer-Verlag
Year: 2006
Tongue: English
Weight: 115 KB
Volume: 17
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s00198-006-0171-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Persistence with teriparatide in postmen

Persistence with teriparatide in postmenopausal osteoporosis; impact of a patient education and follow-up program: the French experience

✍ K. Briot; P. Ravaud; P. Dargent-Molina; M. Zylberman; S. Liu-Leage; C. Roux 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 126 KB

Severe osteoporosis treated with teripar

Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica

✍ L. Moretti; A. Notarnicola; A. Panella; L. Garofalo; R. Garofalo; A. Santamato; 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 168 KB

Teriparatide vs. calcitonin in the treat

Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis

✍ J. S. Hwang; S. T. Tu; T. S. Yang; J. F. Chen; C. J. Wang; K. S. Tsai 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 226 KB

Outcome measurement in work with childre

Outcome measurement in work with children: Comparing plans in the UK with experience in the US

✍ Peter Huxley 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 881 KB

The changes of the calcitonin reserve fu

The changes of the calcitonin reserve function in patients with primary osteoporosis

✍ X. W. Meng; Z. W. Zhan; X. Y. Zhou; W. X. Dai; X. P. Xing; Y. Y. Hu; M. W. Qin 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 132 KB

The persistent anchor of lymph node remo

The persistent anchor of lymph node removal in patients with melanoma

✍ David R. Byrd 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Sentinel lymph node dissection is the most accurate method with which to identify regional metastases in clinically lymph node‐negative patients with melanoma. Attempts to define which sentinel lymph node‐positive patients will benefit from completion lymphadenectomy fall short and raise even more q